Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Valeriia V. Kriukova"'
Autor:
Anastasiia Tsareva, Pavel V. Shelyakin, Irina A. Shagina, Mikhail Yu. Myshkin, Ekaterina M. Merzlyak, Valeriia V. Kriukova, Alexander S. Apt, Irina A. Linge, Dmitriy M. Chudakov, Olga V. Britanova
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Mycobacterium tuberculosis (Mtb) remains a major threat worldwide, although only a fraction of infected individuals develops tuberculosis (TB). TB susceptibility is shaped by multiple genetic factors, and we performed comparative immunological analys
Externí odkaz:
https://doaj.org/article/21bbd6e3c48540329f6d1feed125b949
Autor:
Pavel V. Shelyakin, Ksenia R. Lupyr, Evgeny S. Egorov, Ilya A. Kofiadi, Dmitriy B. Staroverov, Sofya A. Kasatskaya, Valeriia V. Kriukova, Irina A. Shagina, Ekaterina M. Merzlyak, Tatiana O. Nakonechnaya, Elena A. Latysheva, Irina A. Manto, Musa R. Khaitov, Sergey A. Lukyanov, Dmitriy M. Chudakov, Olga V. Britanova
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The interplay between T- and B-cell compartments during naïve, effector and memory T cell maturation is critical for a balanced immune response. Primary B-cell immunodeficiency arising from X-linked agammaglobulinemia (XLA) offers a model to explore
Externí odkaz:
https://doaj.org/article/9b8c5dfdc92d41599dda081cf8de303f
Autor:
Dmitrii S. Shcherbinin, Olga V. Britanova, Vasiliy N Zubov, Evgeny S. Egorov, Nadezhda Logunova, Jens Meiler, Alexander S. Apt, Mikhail V. Pogorelyy, Alina Pereverzeva, Nina G. Bozhanova, Ekaterina M. Merzlyak, Dmitriy M. Chudakov, Pavel V. Shelyakin, Mikhail Shugay, Valeriia V Kriukova
Publikováno v:
Proc Natl Acad Sci U S A
T cell maturation and activation depend upon T cell receptor (TCR) interactions with a wide variety of antigenic peptides displayed in a given major histocompatibility complex (MHC) context. Complementarity-determining region 3 (CDR3) is the most var
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a980c798dcd35593eb94aa7a72a153c1
https://doi.org/10.1073/pnas.2003170117
https://doi.org/10.1073/pnas.2003170117
Autor:
Mathew Clement, Kristin Ladell, Kelly L. Miners, Morgan Marsden, Lucy Chapman, Anna Cardus Figueras, Jake Scott, Robert Andrews, Simon Clare, Valeriia V. Kriukova, Ksenia R. Lupyr, Olga V. Britanova, David R. Withers, Simon A. Jones, Dmitriy M. Chudakov, David A. Price, Ian R. Humphreys
Inhibitory CD4+ T cells have been linked with suboptimal immune responses against cancer and pathogen chronicity, but the mechanisms that underpin the development of such regulatory networks in vivo have remained obscure. To address this knowledge ga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76df9b035acfe053f4830024a303462d
https://doi.org/10.1101/2022.01.25.477742
https://doi.org/10.1101/2022.01.25.477742
Autor:
Mathew Clement, Kristin Ladell, Kelly L Miners, Morgan Marsden, Lucy Chapman, Anna Cardus Figueras, Jake Scott, Robert Andrews, Simon Clare, Valeriia V Kriukova, Ksenia R Lupyr, Olga V Britanova, David R Withers, Simon A Jones, Dmitriy M Chudakov, David A Price, Ian R Humphreys
Publikováno v:
eLife, Vol 12 (2023)
Inhibitory CD4+ T cells have been linked with suboptimal immune responses against cancer and pathogen chronicity. However, the mechanisms that underpin the development of these regulatory cells, especially in the context of ongoing antigen exposure,
Externí odkaz:
https://doaj.org/article/2ebd05a7a8214cc583977dd47ed817fc
Autor:
Mahdy AKH; Institute of Clinical Molecular Biology, Kiel University & University Medical Centre Schleswig-Holstein, Kiel, 24105, Germany., Lokes E; Institute of Clinical Molecular Biology, Kiel University & University Medical Centre Schleswig-Holstein, Kiel, 24105, Germany., Schöpfel V; Institute of Clinical Molecular Biology, Kiel University & University Medical Centre Schleswig-Holstein, Kiel, 24105, Germany., Kriukova V; Institute of Clinical Molecular Biology, Kiel University & University Medical Centre Schleswig-Holstein, Kiel, 24105, Germany., Britanova OV; Institute of Clinical Molecular Biology, Kiel University & University Medical Centre Schleswig-Holstein, Kiel, 24105, Germany., Steiert TA; Institute of Clinical Molecular Biology, Kiel University & University Medical Centre Schleswig-Holstein, Kiel, 24105, Germany., Franke A; Institute of Clinical Molecular Biology, Kiel University & University Medical Centre Schleswig-Holstein, Kiel, 24105, Germany. Electronic address: a.franke@ikmb.uni-kiel.de., ElAbd H; Institute of Clinical Molecular Biology, Kiel University & University Medical Centre Schleswig-Holstein, Kiel, 24105, Germany. Electronic address: h.elabd@ikmb.uni-kiel.de.
Publikováno v:
Journal of autoimmunity [J Autoimmun] 2024 Nov 20; Vol. 149, pp. 103337. Date of Electronic Publication: 2024 Nov 20.